Fig. 2b

Impact of FS-108 on G₂/M transition regulators. HCC827, HCC827/GR6, NCI-H1650, and NCI-H1975 cells were treated with gefitinib or FS-108 at the indicated concentrations for 24 h and the cell lysates were immunoblotted with the indicated antibodies.